发明名称 HUMAN ANTIBODY SPECIFIC TO HUMAN METAPNEUMOVIRUS, OR ANTIGEN-BINDING FRAGMENT THEREOF
摘要 The present invention provides a novel human-derived monoclonal antibody specifically binding to human metapneumovirus F protein and neutralizing the human metapneumovirus, and an antigen-binding fragment thereof. The present invention also provides a pharmaceutical composition comprising the antibody or an antigen-binding fragment thereof.
申请公布号 US2015322137(A1) 申请公布日期 2015.11.12
申请号 US201414761879 申请日期 2014.01.28
申请人 EVEC INC. 发明人 TAKADA Kenzo;NAKAJIMA Kantou
分类号 C07K16/10 主分类号 C07K16/10
代理机构 代理人
主权项 1. An antibody capable of specifically binding to human metapneumovirus F protein and neutralizing its biological activity, or an antigen-binding fragment thereof, comprising a heavy chain variable region and a light chain variable region wherein (i) the heavy chain variable region comprises: (a) the amino acid sequence of heavy chain CDR1 selected from the group consisting of the amino acid sequences of SEQ ID NOs: 3, 13, 23, 33, 43, 53, 63, 73, 83, 93, 103, 113, and 123 and amino acid sequences derived from any of these amino acid sequences by the deletion, substitution, insertion, and/or addition mutations of one to several amino acid residues, (b) the amino acid sequence of heavy chain CDR2 selected from the group consisting of the amino acid sequences of SEQ ID NOs: 4, 14, 24, 34, 44, 54, 64, 74, 84, 94, 104, 114, and 124 and amino acid sequences derived from any of these amino acid sequences by the deletion, substitution, insertion, and/or addition mutations of one to several amino acid residues, and (c) the amino acid sequence of heavy chain CDR3 selected from the group consisting of the amino acid sequences of SEQ ID NOs: 5, 15, 25, 35, 45, 55, 65, 75, 85, 95, 105, 115, and 125 and amino acid sequences derived from any of these amino acid sequences by the deletion, substitution, insertion, and/or addition mutations of one to several amino acid residues, and (ii) the light chain variable region comprises: (a) the amino acid sequence of light chain CDR1 selected from the group consisting of the amino acid sequences of SEQ ID NOs: 8, 18, 28, 38, 48, 58, 68, 78, 88, 98, 108, 118, and 128 and amino acid sequences derived from any of these amino acid sequences by the deletion, substitution, insertion, and/or addition mutations of one to several amino acid residues, (b) the amino acid sequence of light chain CDR2 selected from the group consisting of the amino acid sequences of SEQ ID NOs: 9, 19, 29, 39, 49, 59, 69, 79, 89, 99, 109, 119, and 129 and amino acid sequences derived from any of these amino acid sequences by the deletion, substitution, insertion, and/or addition mutations of one to several amino acid residues, and (c) the amino acid sequence of light chain CDR3 selected from the group consisting of the amino acid sequences of SEQ ID NOs: 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, and 130 and amino acid sequences derived from any of these amino acid sequences by the deletion, substitution, insertion, and/or addition mutations of one to several amino acid residues.
地址 Hokkaido JP